Yoshiya Horimoto

Juntendo University Graduate School of Medicine

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (26)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Hidetaka Eguchi

Associate Professor

Juntendo University

JAPAN

View details

Takashi Yao

Juntendo University

JAPAN

View details

Rongrong Wu

Roswell Park Comprehensive Cancer Center

UNITED STATES

View details

Kaori Denda-Nagai

Project Assistant Professor

Juntendo University

JAPAN

View details

Mitsue Saito

JAPAN

View details

TAKUO HAYASHI

Juntendo University Graduate School of Medicine

JAPAN

View details

Soh Okano

Juntendo University

JAPAN

View details

Junichiro Watanabe

Professor

Juntendo University

JAPAN

View details

Ritsuko Sasaki

Juntendo University Hospital

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yoshiya Horimoto

Research Interests

Explore related searches

Contact this professor

Articles (26)

Clinicopathological characteristics of Japanese patients with breast cancer and MET exon 14 skipping alterations

Hsa-miR-155-5p expression in primary breast tissue may have the potential for prediction of breast cancer brain recurrence: results from the multi-institutional exploratory cohort study

Sustained-release of 4-hydroxytamoxifen inhibits capsular contracture after breast implant placement in a mouse model

Breast tumors with intermediate ER expression differ biologically from ER-low tumors and exhibit a more favorable prognosis

Assessing the Reliability and Validity of Principles for Health-Related Information on Social Media (PRHISM) for Evaluating Breast Cancer Treatment Videos on YouTube: Instrument Validation Study

Should All Low-Grade Ductal Carcinoma In Situ Be Excised? Implications and Challenges of the COMET Trial

Successful Management of Occult Breast Cancer with a Background of Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Interstitial Pneumonia: A Case Report

Absolute lymphocyte count as a biomarker for best supportive care transition in metastatic breast cancer

Emerging measurements for tumor-infiltrating lymphocytes in breast cancer

Efficacy of radiation therapy in Japanese patients with positive margins after breast-conserving surgery

A case of phyllodes tumor with rapid growth during pregnancy and lactation period: a case report

HER2 staining of breast cancer is reduced under the current protocol of Ventana PATHWAY anti‐HER‐2/neu (4B5)

Comment on ‘An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers’ by Fukui et al.

Granulomatous mastitis forming a well-defined large mass diagnosed by surgical excision: a case report

Possible correlation of apical localization of MUC1 glycoprotein with luminal A-like status of breast cancer

Azithromycin induces read-through of the nonsense Apc allele and prevents intestinal tumorigenesis in C3B6F1 Apc/+ mice

Stromal Ki67 Expression Might be a Useful Marker for Distinguishing Fibroadenoma From Benign Phyllodes Tumor of the Breast

Acute myocarditis during adjuvant therapies for breast cancer: a case report

BRCAness of brain lesions reflects a worse outcome for patients with metastatic breast cancer

IgG4-related mastitis characterized by skin thickening of the breast: a case report

Involvement of kallikrein‐PAR2‐proinflammatory pathway in severe trastuzumab‐induced cardiotoxicity

Tamoxifen-resistant breast cancer cells exhibit reactivity with Wisteria floribunda agglutinin

Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients

Successful treatment with steroid pulse therapy for a COVID-19 case with progressive respiratory failure during treatment for pleural metastasis of breast cancer

Absolute lymphocyte count decreases with disease progression and is a potential prognostic marker for metastatic breast cancer

Clinicopathological Features Related to the Efficacy of CDK4/6 Inhibitor-Based Treatments in Metastatic Breast Cancer

Collaborators (9)

Hidetaka Eguchi

Takashi Yao

Rongrong Wu

Kaori Denda-Nagai

Mitsue Saito

TAKUO HAYASHI

Soh Okano

Junichiro Watanabe

Ritsuko Sasaki

Make your next move.